(Q46547392)

23 December 2017

title

PPARgamma is involved in mesalazine-mediated induction of apoptosis and inhibition of cell growth in colon cancer cells (English)

1 reference

23 December 2017

1 reference

1 reference

7

Jürgen Stein

1 reference

23 December 2017

Stefan Marcel Loitsch

3

object named as

Stefan Loitsch

1 reference

23 December 2017

5

Dieter Steinhilber

1 reference

23 December 2017

6

Oliver Schröder

1 reference

23 December 2017

author name string

Markus Schwab

1

1 reference

23 December 2017

Veerle Reynders

2

1 reference

23 December 2017

Yogesh M Shastri

4

1 reference

23 December 2017

language of work or name

English

0 references

publication date

9 June 2008

1 reference

23 December 2017

published in

Carcinogenesis

1 reference

23 December 2017

volume

29

1 reference

23 December 2017

issue

7

1 reference

23 December 2017

page(s)

1407-1414

1 reference

23 December 2017

5-aminosalicylic acid is an attractive candidate agent for chemoprevention of colon cancer in patients with inflammatory bowel disease

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN118

5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN118

Mesalazine improves replication fidelity in cultured colorectal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN118

PPARgamma as a new therapeutic target in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN118

Mesalazine causes a mitotic arrest and induces caspase-dependent apoptosis in colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN118

Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN118

Peroxisome proliferator-activated receptor gamma: a novel target for cancer therapeutics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN118

Peroxisome proliferator-activated receptors: nuclear control of metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN118

Primary culture model of peroxisome proliferator-activated receptor gamma activity in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN118

Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN118

Differential expression, distribution, and function of PPAR-gamma in the proximal and distal colon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN118

Peroxisome proliferator-activated receptor gamma (PPARgamma) and colorectal carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN118

Induction of differentiation and peroxisome proliferator-activated receptor gamma expression in colon cancer cell lines by troglitazone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN118

Biology of PPAR gamma in cancer: a critical review on existing lacunae

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN118

PPARgamma is a key target of butyrate-induced caspase-3 activation in the colorectal cancer cell line Caco-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN118

A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN118

Target genes of peroxisome proliferator-activated receptor gamma in colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN118

Tumor suppressor and anti-inflammatory actions of PPARgamma agonists are mediated via upregulation of PTEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN118

PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase/Akt-dependent and -independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN118

Sulfasalazine. Multiplicity of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN118

Peroxisome proliferator-activated receptor-gamma ligands as cell-cycle modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN118

Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14-prostaglandin J2 inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase signal pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN118

Dose loading with delayed-release mesalazine: a study of tissue drug concentrations and standard pharmacokinetic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN118

5-aminosalicylic acid enhances anchorage-independent colorectal cancer cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN118

Pioglitazone, a synthetic ligand for PPARgamma, induces apoptosis in RB-deficient human colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN118

Peroxisome proliferator-activated receptor gamma agonists inhibit the proliferation and invasion of human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN118

Growth inhibition and induction of apoptosis in colorectal tumor cells by cyclooxygenase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN118

Peroxisome proliferator-activated receptor ligands affect growth-related gene expression in human leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN118

Suppression of PTEN expression by NF-kappa B prevents apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN118

NSAIDs activate PTEN and other phosphatases in human colon cancer cells: novel mechanism for chemopreventive action of NSAIDs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN118

Adenovirus-mediated transfer of the PTEN gene inhibits human colorectal cancer growth in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN118

Increased PTEN expression due to transcriptional activation of PPARgamma by Lovastatin and Rosiglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN118

Death and anti-death: tumour resistance to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN118

The Chemopreventive Agent Sulindac Attenuates Expression of the Antiapoptotic Protein Survivin in Colorectal Carcinoma Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN118

Loss of inhibitor of apoptosis proteins as a determinant of polyamine analog-induced apoptosis in human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN118

Polyamines as modifiers of genetic risk factors in human intestinal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN118

Activation of peroxisome proliferator-activated receptor-gamma reverses squamous metaplasia and induces transitional differentiation in normal human urothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN118

Loss-of-Function Mutations in PPARγ Associated with Human Colon Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN118

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGN118

1 reference

23 December 2017

1 reference

23 December 2017